All Stories

Phorm Now “In Sights” – Target Price Buttons

Tom Winnifrith
Tuesday 4 March 2014

I wrote earlier today about how I now regarded Phorm (PHRM) as more of a sell than a buy. Following extensive conversations with a number of folks I now have it officially “in sights.”

Previous companies to be accorded that honour were – until they were forced to changed management - Sefton (SER) and Vialogy (VIY). We all know what happened there. 

My target price for this company – now trading at 13.5p – valuing the enterprise at a preposterous £65 million – is buttons.  More to follow….

If you enjoyed reading this article from Tom Winnifrith, why not help us cover our running costs with a donation?

Filed under:

About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Recently Featured on ShareProphets
Sign up for my weekly newsletter








Required Reading

Recent Comments


I also read